-
DE
The Factor 5 Leiden mutation is a genetic change that significantly increases the risk of blood clots. It is the most common inherited cause of clotting disorders in people of European descent.
Regular tips about health Regular tips about health Add as Preferred SourceThe Factor 5 Leiden mutation is a genetic change that significantly increases the risk of blood clots. It is the most common inherited cause of clotting disorders in people of European descent.
The Factor 5 Leiden mutation (also written as Factor V Leiden mutation) is a genetic variant in the gene encoding clotting factor V. This variant prevents factor V from being properly inactivated, causing the blood to remain in an overactive clotting state. As a result, affected individuals have a significantly increased risk of developing blood clots (thrombosis). It is the most common inherited thrombophilia in European populations, affecting approximately 3–8% of individuals of European descent.
The mutation is caused by a single nucleotide substitution in the F5 gene on chromosome 1 (guanine replaced by adenine, G1691A). This leads to an amino acid change in the factor V protein (arginine replaced by glutamine at position 506, R506Q), making the mutated factor V resistant to inactivation by the natural anticoagulant activated protein C (APC).
The mutation follows an autosomal dominant inheritance pattern:
The Factor 5 Leiden mutation itself does not cause direct symptoms. However, it significantly increases the risk of the following conditions:
Many carriers of the mutation never experience a thrombotic event, especially in the absence of additional risk factors.
The thrombosis risk increases substantially when the Factor 5 Leiden mutation is combined with other risk factors such as:
Diagnosis is established through laboratory testing on a blood sample, using two main approaches:
Testing is typically recommended in individuals with:
Carriers of the Factor 5 Leiden mutation do not automatically require treatment. Management is individualized based on the overall thrombotic risk assessment.
Pregnant carriers are often treated with low-molecular-weight heparin, as DOACs are contraindicated during pregnancy. Treatment decisions are made on an individual basis in close consultation with a physician.
As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.
Average rating of 4.97 out of 5 stars
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
Average rating of 4.85 out of 5 stars
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
Average rating of 4.87 out of 5 stars
Daily basic supply: the complete spectrum of micronutrients
Natural multivitamin complex for the immune system, energy, and central body functions
Average rating of 4.94 out of 5 stars
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.